Functional genomic analyses of the gut microbiota for CRC screening

[1]  E. Zoetendal,et al.  Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. , 2013, The American journal of clinical nutrition.

[2]  Fredrik H. Karlsson,et al.  Gut metagenome in European women with normal, impaired and diabetic glucose control , 2013, Nature.

[3]  F. Guarner,et al.  Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission , 2013, Inflammatory bowel diseases.

[4]  Alison S. Waller,et al.  Genomic variation landscape of the human gut microbiome , 2012, Nature.

[5]  C. Datz,et al.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth , 2012, Nature.

[6]  G. Gibson,et al.  Gut microbial activity, implications for health and disease: the potential role of metabolite analysis. , 2012, Journal of proteome research.

[7]  Belgin Dogan,et al.  Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota , 2012, Science.

[8]  Qiang Feng,et al.  A metagenome-wide association study of gut microbiota in type 2 diabetes , 2012, Nature.

[9]  M. Kleerebezem,et al.  The impact of probiotics and prebiotics on the immune system , 2012, Nature Reviews Immunology.

[10]  Ruslan Medzhitov,et al.  Evolution of Inflammatory Diseases , 2012, Current Biology.

[11]  W. M. Vos,et al.  Role of the intestinal microbiome in health and disease: from correlation to causation , 2012 .

[12]  M. Lane,et al.  Cell-Free Supernatants from Probiotic Lactobacillus casei and Lactobacillus rhamnosus GG Decrease Colon Cancer Cell Invasion In Vitro , 2012, Nutrition and cancer.

[13]  T. Levin,et al.  Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. , 2012, Gastroenterology.

[14]  T. Klaenhammer,et al.  Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid , 2012, Proceedings of the National Academy of Sciences.

[15]  A. Macpherson,et al.  Interactions Between the Microbiota and the Immune System , 2012, Science.

[16]  Michael A Choti,et al.  Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. , 2012, Journal of the American College of Surgeons.

[17]  S. Lightfoot,et al.  4-hydroxy-2-nonenal mediates genotoxicity and bystander effects caused by Enterococcus faecalis-infected macrophages. , 2012, Gastroenterology.

[18]  M. Rescigno,et al.  Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model , 2012, Gut.

[19]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[20]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[21]  Aldert L. Zomer,et al.  Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection , 2012, Proceedings of the National Academy of Sciences.

[22]  D. Kasper,et al.  The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA , 2012, Immunological reviews.

[23]  A. Moschetta,et al.  Bile acids and colon cancer: Solving the puzzle with nuclear receptors. , 2011, Trends in molecular medicine.

[24]  Tzou-Yien Lin,et al.  Oral inoculation of probiotics Lactobacillus acidophilus NCFM suppresses tumour growth both in segmental orthotopic colon cancer and extra-intestinal tissue , 2011, British Journal of Nutrition.

[25]  Tarah Lynch,et al.  Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.

[26]  Ateequr Rehman,et al.  Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. , 2011, Gastroenterology.

[27]  M. Washington,et al.  Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism. , 2011, The Journal of clinical investigation.

[28]  E. Allen-Vercoe,et al.  Fusobacterium nucleatum Infection of Colonic Cells Stimulates MUC2 Mucin and Tumor Necrosis Factor Alpha , 2011, Infection and Immunity.

[29]  S. D. De Keersmaecker,et al.  Exopolysaccharides of Lactobacillus rhamnosus GG form a protective shield against innate immune factors in the intestine , 2011, Microbial biotechnology.

[30]  C. Grangette,et al.  Anti-inflammatory capacity of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide , 2011, Gut.

[31]  T. Klaenhammer,et al.  Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid , 2011, Proceedings of the National Academy of Sciences.

[32]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[33]  Mario Plebani,et al.  Pathogenesis of Helicobacter pylori Infection , 2010, Helicobacter.

[34]  S. Mazmanian,et al.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[35]  T. Strom,et al.  T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. , 2009, Cancer research.

[36]  W. D. de Vos,et al.  S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions , 2008, Proceedings of the National Academy of Sciences.

[37]  K. Madsen,et al.  Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[38]  J. Doré,et al.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients , 2008, Proceedings of the National Academy of Sciences.

[39]  R. Hughes,et al.  Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. , 2007, The American journal of clinical nutrition.

[40]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[41]  M. Affolter,et al.  A Serpin from the Gut Bacterium Bifidobacterium longum Inhibits Eukaryotic Elastase-like Serine Proteases* , 2006, Journal of Biological Chemistry.

[42]  T. Hartung,et al.  Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Laurent Beaugerie,et al.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. , 2004, Gastroenterology.

[44]  C. Hart,et al.  Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer. , 2004, Gastroenterology.

[45]  T. Warner,et al.  Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. , 2002, The American journal of pathology.